CCELCRYO CELL INTERNATIONAL INCvs its industry peers
A metric-by-metric comparison of CRYO CELL INTERNATIONAL INC against SIC 8090 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CCELThis | $41M#6 | — | — | 1.3x#3 | -1.3%#3 | -704.2%#5 | 1.5%#3 | — | — | — | — | 7.9%#1 |
| DVA | $11.8B#1 | 13.9x#1 | — | 0.9x#2 | 6.5%#2 | -13.8%#2 | 15.0%#1 | — | 34.3%#1 | — | 57.9%#2 | — |
| PGNY | $2.2B#3 | 31.8x#2 | 4.9x#2 | 1.7x#4 | 10.4%#1 | 7.7%#1 | 6.6%#2 | 12.9%#1 | 17.4%#2 | — | 56.7%#3 | — |
| AGL | $1.4B#4 | — | 3.0x#1 | 0.2x#1 | -2.1%#4 | -50.4%#3 | -7.8%#5 | -83.1%#3 | -117.6%#4 | — | 317.6%#1 | — |
| FMS | $6.3B#2 | — | — | — | — | — | — | — | — | — | — | — |
| MCTA | $471M#5 | — | 90.8x#3 | 97.9x#5 | -22.7%#5 | -101.9%#4 | -0.6%#4 | -0.4%#2 | 0.0%#3 | — | 0.0%#4 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 8090). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice